ILMN Illumina Platform Expected net earnings per share growth this year

ILMN (illumina.com) - company brandmark

Business stabilization under Jacob an Illumina, Inc. (ILMN) leadership creates a foundation for recovery, as evidenced by the YoY earnings per share dynamics, where the latest value is recorded as 12.00. Its status as a global genetics pioneer with impeccable authority provides the bedrock for growth. Financial stability is based on a closed-loop supply model for consumables for installed equipment.

ILMN Illumina Inc Earnings per share growth in current year (07/04/2022 - 11/17/2026)

Comprehensive metric breakdowns and analytics for illumina.com (ILMN)

- current quotes and average value forecast:
Basic company analysis:ILMN, Illumina Corp
Finished products of Illumina, Inc.

This indicator reflects the monetization efficiency of Illumina, Inc. sequencing technologies by measuring the percentage deviation of current earnings per share from the same period last year. By analyzing the historical annual trend of net earnings per share, an investor assesses the actual capital inflow, which in this case should confirm cost reductions following the Grail spin-off and the commercial success of the NovaSeq X platform.

Direct competitors

Net earnings per share change in current year Agilent Tech A|Earnings per share growth in current year Quest Corp|Exact Sciences (EXAS) - Expected net earnings per share growth this year|Earnings per share growth in current year Revvity (RVTY)|Expected net earnings per share growth this year Bio-Rad Laboratories, Inc.|Earnings per share growth in current year Anbio Biotechnology NNNN|Net earnings per one share growth for the current year SHC (Sterigenics)|quidel.com - Earnings growth in current year|Earnings per share growth rate in current year OPKO Health|CDNA: Earnings growth in current year|Maravai LifeSciences Corp (MRVI) - Earnings growth in current year|FLGT (fulgentgenetics.com) - Earnings growth in current year|Earnings growth in current year Standard BioTools Corp|Net earnings per share growth this year CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Earnings per share increase in current year|Earnings growth in current year XGN (exagen.com)|MDxHealth Inc. - Earnings per share growth in current year|Lucid Diagnostics, Inc - Earnings growth in current year|Expected net earnings per share growth this year Prenetics Global Limited PRE|Insight Molecular (IMDX) - Earnings per share growth in current year|TRIB (Trinity Biotech PLC) - Earnings per share growth in current year|Earnings per share growth in current year ProPhase Labs|Ainos (AIMD) - Expected net earnings per share growth this year|Net earnings per share growth this year CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Earnings per share increase in current year|Earnings per share growth in current year Biomerica BMRA|CDIO: Earnings per share growth this year|Onconetix Inc - Earnings growth in current year|Expected net earnings per share growth this year Virax Biolabs Group Ltd VRAX|bluejaydx.com (BJDX) - Earnings per share growth in current year|Vermillion - Earnings per share increase in current year|AXDX (Accelerate Diagnostics Inc) - Earnings growth in current year|Net earnings per share growth this year CENTOGENE, N.V. (CNTG)|Net earnings per share growth this year ENZ (Enzo)|Earnings growth in current year Fresh2 Group Limited (FRES)|Earnings growth in current year GENE (GTG Labs)|ME - Net earnings per share growth this year|Psychemedics Inc - Earnings growth in current year